Methotrexaat Teva

Methotrexate, the active ingredient in Methotrexaat Teva, is an antimetabolite (folate antagonist) presented as an oral tablet for oral use. It treats rheumatoid arthritis, psoriasis, acute lymphoblastic leukemia, non‑Hodgkin lymphoma and other malignancies responsive to antimetabolite therapy.

GNH USA supplies Methotrexaat Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Methotrexate is used in autoimmune and oncologic disease pathways to modulate cell proliferation and immune activity.

Rheumatoid arthritis: reduces joint inflammation and slows disease progression. Psoriasis: decreases skin cell turnover and plaque formation. Acute lymphoblastic leukemia: interferes with malignant lymphoblast replication. Non‑Hodgkin lymphoma: impedes growth of lymphoma cells. Other malignancies responsive to antimetabolite therapy: provides cytotoxic effects against rapidly dividing tumor cells.

Methotrexate may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea and vomiting - Mucositis or mouth sores - Fatigue or weakness - Alopecia (hair loss) - Elevated liver enzymes - Mild skin rash

Serious or Rare Side Effects: - Bone marrow suppression leading to pancytopenia - Severe hepatic toxicity or fibrosis - Pulmonary fibrosis or interstitial pneumonitis - Life‑threatening infections due to immunosuppression - Renal impairment or failure - Severe cutaneous reactions such as Stevens‑Johnson syndrome

Before initiating therapy, several safety considerations should be addressed.

Monitor blood counts: perform regular complete blood count assessments. Assess liver function: check hepatic enzymes periodically. Evaluate renal function: adjust dosing if creatinine clearance is reduced. Avoid in pregnancy: teratogenic risk requires effective contraception. Review concomitant nephrotoxic or hepatotoxic drugs: adjust or discontinue as needed. Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Methotrexate interacts with several medicines that can alter its efficacy or toxicity.

Major Interactions (Avoid): - NSAIDs: increase methotrexate plasma levels and risk of toxicity. - Trimethoprim‑sulfamethoxazole: potentiate myelosuppression. - Live vaccines: may cause uncontrolled infection due to immunosuppression.

Moderate Interactions (Monitor Closely): - Proton pump inhibitors: may affect renal clearance. - Penicillins and other β‑lactam antibiotics: modestly increase toxicity risk. - Alcohol: can exacerbate hepatic injury.